Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD

被引:3
|
作者
Nag, Niharika [1 ]
Tripathi, Timir [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793022, India
[2] Indira Gandhi Natl Open Univ IGNOU, Reg Directors Office, Reg Ctr Kohima, Kohima 797001, India
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 17期
关键词
Nucleocytoplasmic transport; amyotrophic lateral sclerosis; ALS/FTLD; Nup62; proteinopathy; TDP-43; FG-Nups; condensates; NUCLEOCYTOPLASMIC TRANSPORT; DISRUPTS;
D O I
10.1021/acschemneuro.2c00480
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nucleocytoplasmic transport (NCT) is impaired in C9-ALS/FTLD, a common genetically caused form of ALS and FTLD. The NCT is regulated by proteins called FG-nucleoporins (FG-Nups), with domains enriched in phenylalanine-glycine repeats. However, the relationship between FG-Nups and TDP-43, an RBP found to be mislocalized in ALS/FTLD patients, has not been defined. A recent study found that a critical protein, FG-Nup62, is mislocalized both in vivo and in vitro in diseased states. The mislocalized Nup62 was colocalized with TDP-43 in cytoplasmic inclusions and promoted its liquid-to-solid transition. The work highlights the involvement of Nup62 in the pathogenesis of ALS/FTLD and the interaction between Nup62 and TDP-43.
引用
收藏
页码:2544 / 2546
页数:3
相关论文
共 50 条
  • [1] NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
    Amanda M. Gleixner
    Brandie Morris Verdone
    Charlton G. Otte
    Eric N. Anderson
    Nandini Ramesh
    Olivia R. Shapiro
    Jenna R. Gale
    Jocelyn C. Mauna
    Jacob R. Mann
    Katie E. Copley
    Elizabeth L. Daley
    Juan A. Ortega
    Maria Elena Cicardi
    Evangelos Kiskinis
    Julia Kofler
    Udai B. Pandey
    Davide Trotti
    Christopher J. Donnelly
    Nature Communications, 13
  • [2] NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
    Gleixner, Amanda M.
    Verdone, Brandie Morris
    Otte, Charlton G.
    Anderson, Eric N.
    Ramesh, Nandini
    Shapiro, Olivia R.
    Gale, Jenna R.
    Mauna, Jocelyn C.
    Mann, Jacob R.
    Copley, Katie E.
    Daley, Elizabeth L.
    Ortega, Juan A.
    Cicardi, Maria Elena
    Kiskinis, Evangelos
    Kofler, Julia
    Pandey, Udai B.
    Trotti, Davide
    Donnelly, Christopher J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] ALS and FTLD: two faces of TDP-43 proteinopathy
    Liscic, R. M.
    Grinberg, L. T.
    Zidar, J.
    Gitcho, M. A.
    Cairns, N. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) : 772 - 780
  • [4] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181
  • [5] TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
    Atkinson, Rachel
    Leung, Jacqueline
    Bender, James
    Kirkcaldie, Matthew
    Vickers, James
    King, Anna
    DISEASE MODELS & MECHANISMS, 2021, 14 (02)
  • [6] The role of TDP-43 in the pathogenesis of ALS and FTLD
    Baralle, Marco
    Buratti, Emanuele
    Baralle, Francisco E.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1536 - 1540
  • [7] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8
  • [8] Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid
    Bigio, Eileen H.
    Wu, Jane Y.
    Deng, Han-Xiang
    Bit-Ivan, Esther N.
    Mao, Qinwen
    Ganti, Rakhee
    Peterson, Melanie
    Siddique, Nailah
    Geula, Changiz
    Siddique, Teepu
    Mesulam, Marsel
    ACTA NEUROPATHOLOGICA, 2013, 125 (03) : 463 - 465
  • [9] Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid
    Eileen H. Bigio
    Jane Y. Wu
    Han-Xiang Deng
    Esther N. Bit-Ivan
    Qinwen Mao
    Rakhee Ganti
    Melanie Peterson
    Nailah Siddique
    Changiz Geula
    Teepu Siddique
    Marsel Mesulam
    Acta Neuropathologica, 2013, 125 : 463 - 465
  • [10] Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD
    Copley, Katie
    Smirnov, Ashleigh
    Mayne, Leland
    Wang, Yuanhang
    Black, Ben E.
    Shorter, James
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 485A - 486A